Thrombophilia Testing

  • Teresa L. Carman


Hypercoagulable testing is an area of clinical medicine fraught with misconception and misunderstanding. We all desire to provide our patients with the best possible diagnosis and understanding of their medical condition. However, laboratory testing for thrombophilia is overused, frequently misunderstood, and in many cases ordered without a good understanding of the results. Laboratory testing for thrombophilia may be affected by many patient-related, therapy-related, and laboratory-related factors. An understanding of these influences will lead to a better understanding of when testing may be warranted. The diagnosis of a thrombophilic state may impact future care and decisions on anticoagulation and periprocedural or peripartum care. In addition, overuse and inappropriately timed hypercoagulable testing can impact the cost of care, length of stay, and immediate as well as long-term anticoagulation decisions. The savvy practitioner should seek to gain an understanding of the pearls and pitfalls of thrombophilia testing. This chapter will strive to help determine the optimal tests, timing of testing, and impact of hypercoagulable testing for patients with venous and arterial thromboembolism.


Hypercoagulable testing Thrombophilia Thrombophilia testing Laboratory testing Thrombosis Venous thromboembolism Arterial thrombosis Antiphospholipid antibody syndrome Natural anticoagulant deficiency Factor V Leiden Prothrombin gene mutation 


  1. 1.
    American Society of Hematology. Ten Things Physicians and Patients Should Question.
  2. 2.
    Mannucci PM, Franchini M. Classic thrombophilic gene variants. Thromb Haemost. 2015;114:885–9.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464–74.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Morange PE, Tregouet DA. Current knowledge on the genetics of incident venous thromboembolism. J Thromb Haemost. 2013;11(suppl 1):111–21.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Heit JA, Ashrani A, Crusan DJ, McBane RD, Petterson TM, Bailey KR. Reasons for the persistent incidence of venous thromboembolism. Thromb Haemost. 2017;117(2):390–400.CrossRefGoogle Scholar
  6. 6.
    Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41:3–14.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Khor B, Van Cott EM. Laboratory testing for antithrombin deficiency. Am J Hematol. 2010;85:947–50.CrossRefGoogle Scholar
  8. 8.
    Khor B, Van Cott EM. Laboratory tests for protein C deficiency. Am J Hematol. 2010;85:440–2.CrossRefGoogle Scholar
  9. 9.
    Eby C. Laboratory aspects of Thrombophilia testing. In: Kotte-Marchant K, editor. An algorithmic approach to hemostasis testing. Northfield: College of American Pathologists (CAP); 2008.Google Scholar
  10. 10.
    Marlar RA, Gausman JN. Protein S abnormalities: a diagnostic nightmare. Am J Hematol. 2011;86:418–21.CrossRefPubMedGoogle Scholar
  11. 11.
    Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol. 2016;91:46–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Kadauke S, Khor B, Van Cott EM. Activated protein C resistance testing for factor V Leiden. Am J Hematol. 2014;89:1147–50.CrossRefPubMedGoogle Scholar
  13. 13.
    Castaman G, Faioni EM, Tosetto A, Bernardi F. The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis. Haematologica. 2003;88:1182–9.PubMedGoogle Scholar
  14. 14.
    Cosmi B, Legnani C, Cini M, Favaretto E, Palareti G. D-dimer and factor FVIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Res. 2008;122:610–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Jenkins VP, Rawley O, Smith OP, O’Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012;157:653–66.CrossRefPubMedGoogle Scholar
  16. 16.
    Cushman M, O’Meara ES, Folsom AR, Heckbert SR. Coagulation facotes IX through XIII and the risk of future venous thrombosis: the longitudinal investigation of thromboembolism etiology. Blood. 2009;114:2878–83.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Key NS. Epidemiology and clinical data linking factors XI and XII to thrombosis. Hematology Am Soc Hematol Educ Program. 2014;2104(1):66–70.Google Scholar
  18. 18.
    Casini A, Neerman-Arbex M, Ariens RA, De Moerloose P. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. J Thromb Haemost. 2015;13:909–19.CrossRefGoogle Scholar
  19. 19.
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid antibody syndrome (APS). J Thromb Haemost. 2006;4:295–306.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Salmon JE, de Groot PG. Pathogenic role of antiphospholipid antibodies. Lupus. 2008;17:405–11.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Chaturvedi S, McCrae KR. The antiphospholipid syndrome still an enigma. Hematology Am Soc Hematol Educ Program. 2015;2015:53–60.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Giannakopoulos B, Passam F, Ioannou Y, Krillis SA. How we diagnosis the antiphospholipid syndrome. Blood. 2009;113:985–94.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Giannakopoulos B, Passam F, Soheila R, Krillis SA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood. 2007;109:422–30.CrossRefPubMedGoogle Scholar
  24. 24.
    MaIntyre JA, Wagenknech DR, Waxman DW. Frequency and specificities if antiphospholipid antibodies (aPL) in volunteer blood donors. Immunobiology. 2003;207:59–63.CrossRefGoogle Scholar
  25. 25.
    Franchini M, Martinelli I, Mannucci PM. Uncertain thrombophilia markers. Thromb Haemost. 2016;115:25–30.CrossRefPubMedGoogle Scholar
  26. 26.
    Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007;131:872.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Cardiovascular MedicineUniversity Hospitals Cleveland Medical CenterClevelandUSA
  2. 2.Department of MedicineCase Western Reserve University School of MedicineClevelandUSA

Personalised recommendations